BIOTISSUE
LIVE

Serial Number

97588024

Owner

BIOTISSUE HOLDINGS INC.

Attorney

Alyssa M. Worsham

First Use Date

Jul 12, 2022

Filing Date

Sep 12, 2022

Add to watchlist:

No watchlists yet
View on USPTO

BIOTISSUE Trademark

Serial Number: 97588024 • Registration: 7872385

BIOTISSUE is a trademark filed by BIOTISSUE HOLDINGS INC. on September 12, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

BIOTISSUE HOLDINGS INC. (21 trademarks)

7300 CORPORATE CENTER DRIVE, SUITE 700
MIAMI, FL 33126

Entity Type: 03

Trademark Details

Filing Date

September 12, 2022

Registration Date

July 22, 2025

First Use Anywhere

July 12, 2022

First Use in Commerce

July 12, 2022

Goods & Services

Therapeutic products in the nature of biologic bandages for the treatment of eye diseases; pharmaceutical preparations for treating diseases and disorders affecting the eye; implants of human tissue for guided tissue regeneration; surgical implants comprised of human tissues; surgical implants grown from stem cells; stem cells for medical purposes; tissue-regenerative medical preparations; transplants, namely, human tissues for transplant purposes

surgical implants comprised of natural, non-living materials for use in guided tissue regeneration; artificial replacement materials for human tissue, namely, synthetic collagen based scaffolding materials; guided tissue regeneration materials in the nature of natural, non-living bone grafts; implantable surgical textile material to encourage the growth of tissue; implants comprising natural, non-living materials for guided tissue regeneration; implant materials in the nature of implantable natural, non-living tissues for use in guided tissue regeneration in surgery; implants comprising of natural, non-living tissue for guided tissue regeneration; surgical natural, non-living tissue grafts

Biologic research; scientific research and development in the field of biologics and regenerative medicine

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jul 22, 2025 NRCS
REGISTERED-SUPPLEMENTAL REGISTER
Jul 22, 2025 R.SR
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Jun 17, 2025 CNTA
USE AMENDMENT ACCEPTED
Jun 17, 2025 IUAA
ASSIGNED TO EXAMINER
May 28, 2025 DOCK
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Aug 29, 2024 ASGN
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Aug 22, 2024 AMPX
TEAS VOLUNTARY AMENDMENT RECEIVED
Aug 22, 2024 PARI
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 29, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 29, 2024 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Jul 29, 2024 ERFR
AMENDMENT TO USE PROCESSING COMPLETE
Jun 20, 2024 AUPC
USE AMENDMENT FILED
Jun 20, 2024 IUAF
TEAS AMENDMENT OF USE RECEIVED
Jun 20, 2024 EAAU
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Apr 23, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Apr 23, 2024 XELR
NOTIFICATION OF FINAL REFUSAL EMAILED
Feb 8, 2024 GNFN
FINAL REFUSAL E-MAILED
Feb 8, 2024 GNFR
FINAL REFUSAL WRITTEN
Feb 8, 2024 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 22, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 21, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 21, 2023 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Sep 27, 2023 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Sep 27, 2023 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 28, 2023 GNRN
NON-FINAL ACTION E-MAILED
Jun 28, 2023 GNRT
NON-FINAL ACTION WRITTEN
Jun 28, 2023 CNRT
ASSIGNED TO EXAMINER
Jun 23, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 28, 2022 NWOS
NEW APPLICATION ENTERED
Sep 15, 2022 NWAP